ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 304421 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 304421; 2) Community: the network communities that were significantly associated with the response to NSC 304421; 3) Molecule: the relationships between components within communities and NSC 304421; 4) MDR: the compounds that were significantly associated with the NSC 304421.

NSC Compound Enrichment Correlation
NSC 382585 Null 0.0423559437159349 -0.0088858854
NSC 49460 Null 0.0423559437159349 0.27135091
NSC 57187 Null 0.0423559437159349 0.13273454
NSC 642316 ANTINEOPLASTIC-642316 0.0423559437159349 0.43541545
NSC 668498 Null 0.0423559437159349 0.15646729
NSC 669509 Null 0.0423559437159349 0.19411976
NSC 673191 Null 0.0423559437159349 0.39193013
NSC 684909 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 0.0423559437159349 -0.06228531
NSC 687369 Null 0.0423559437159349 -0.1337765
NSC 692655 D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate 0.0423559437159349 0.17790911
Total:31  Current:27    [First] [Prev] [Next] [Last]